¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõ¹«¸­°üÀý¿° Ä¡·á ´Ù¾çÇÑ Ä¡·á¸¦

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#ÀÎõ¹«¸­°üÀý¿°, #ÀÎõ¹«¸­°üÀý¿°Ä¡·á, #¹«¸­ÅðÇ༺°üÀý¿°, #ÀÎõ¹«¸­ÅðÇ༺°üÀý¿°, #¹«¸­°üÀý¿°Ä¡·á, #¹«¸­ÅðÇ༺°üÀý¿°Ä¡·á, #ÀÎõ¹«¸­ÅðÇ༺°üÀý¿°, #¿¬¼ö±¸¹«¸­°üÀý¿° ÀÎõ¹«¸­°üÀý¿°,,ÀÎõ¹«¸­°üÀý¿°Ä¡·á,,¹«¸­ÅðÇ༺°üÀý¿°,,ÀÎõ¹«¸­ÅðÇ༺°üÀý¿°,,¹«¸­°üÀý¿°Ä¡·á,,¹«¸­ÅðÇ༺°üÀý¿°Ä¡·á,,ÀÎõ¹«¸­ÅðÇ༺°üÀý¿°,,¿¬¼ö±¸¹«¸­°üÀý¿° ¾È³çÇϼ¼¿ä. ÀÎõ¹«¸­°üÀý¿° ¿¬¼ö±¸ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ÀÎõ¹«¸­°üÀý¿° ¿¬¼ö±¸ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ÀÎõÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â¹«¸­ÅðÇ༺°üÀý¿°, ¹«¸­¿¬°ñ¿¬È­Áõ, ¹«¸­°üÀý¿°Áõ, ½ÊÀÚÀδëÆÄ¿­, ½½°³´ëÅðÁõÈıº, ¿À½º±Â½¶¶óÅͺ´, ¹«¸­¿¬°ñ¼Õ»óÁõ»ó, ÅðÇ༺¹«¸­°üÀý¿°, ¹«¸­ÅëÁõ, Á¡¾×³¶¿°, ³»¹Ý½½±³Á¤, °ÅÀ§¹ß°Ç¿°, Àå°æÀδ뿰, ¹«¸­ÅëÁõ¿ÏÈ­, ¹«¸­¿¬°ñ¼Õ»ó, ¹«¸­¿·ÅëÁõ, ¿¬°ñ¿¬È­Áõ, ¿À¸¥Âʹ«¸­ÅëÁõ, ¹«¸­°üÀý¿°, ¹«¸­µÚ±ÙÀ°, ¹«¸­µÚÂÊÅëÁõ, ¹Ý¿ù»ó¿¬°ñÆÄ¿­, ½½°³¿¬°ñ¿¬È­Áõ, ¹«¸­°Ç¿°, ¿îµ¿¹«¸­ÅëÁõµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó ¹°¸®Ä¡·á, ÀÌ¿ÂÀüÀÚÀڱؿä¹ý, Àû¿Ü¼±¿å, ¿ªÇÐÄ¡·á, Çdz»Ä§, º¹ÇÕ¾àħ, ºñ¸¸È¯ÀÚ°ü¸®, Çâ±âºÐ»ç¿ä¹ý, °æÇÇÀü±âÀڱؿä¹ý, ÀüÀÚ¿ä¹ý, ¾È¸é°èÃø°Ë»ç, ½ÉºÎÈÆÁõ°æ¶ô¾àÂò¿ä¹ý, ÀåħÀü±âÀڱؼú, TENS, üÁú¿ë¸ð°Ë»ç, ±³Á¤Ãß³ª, »ç»óüÁú°Ë»ç, Áö÷¿ëÀû¸ÆÆÄ°Ë»ç, manipulation, ±ØÃÊ´ÜÆÄÅõ¿­Ä¡·á, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç °æºÏ ¾Èµ¿½Ã ÀÓÇϸé, °­¿ø Źé½Ã Źé¿ìü±¹»ç¼­ÇÔ, °æ±â ¼º³²½Ã ¼öÁ¤±¸ ÅÂÆò3µ¿, Àü³² °­Áø±º ¸¶·®¸é, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¹Ú´Þ2µ¿, °æ³² ¹Ð¾ç½Ã È°¼ºµ¿, Á¦ÁÖ Á¦Áֽà ¿ÜµµÀϵ¿, Ãæ³² žȱº ÀÌ¿ø¸é, °­¿ø ȭõ±º »ç³»¸é, ºÎ»ê µ¿·¡±¸ º¹Ãµµ¿, °æ³² â³ç±º ´ëÇÕ¸é, Àü³² ¿©¼ö½Ã ¿¬µîµ¿, °­¿ø Ãáõ½Ã Ãáõ¿ìü±¹»ç¼­ÇÔ, °æºÏ ¾Èµ¿½Ã ¼®µ¿µ¿, Ãæ³² ¿¹»ê±º ´ö»ê¸é, °­¿ø ȫõ±º ºÏ¹æ¸é, °­¿ø ¼ÓÃʽà ¿µ¶ûµ¿, °æºÏ ûµµ±º È­¾çÀ¾, °æ±â ¾È¾ç½Ã µ¿¾È±¸ È£°è2µ¿, °æ³² ³²Çرº »óÁÖ¸é, °æ³² â¿ø½Ã ¼º»ê±¸ õ¼±µ¿, Àü³² ¸ñÆ÷½Ã º¸±¤µ¿2°¡, °æ±â ¼º³²½Ã ¼öÁ¤±¸ ½ÅÈï2µ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ ÆòÈ­µ¿, Àü³² °î¼º±º ¸ñ»çµ¿¸é, Àü³² Áøµµ±º Á¶µµ¸é, °æºÏ ¿µÁֽà ¿µÁÖ¿ìü±¹»ç¼­ÇÔ, °æ±â ¼º³²½Ã ¼öÁ¤±¸ ½ÅÈï2µ¿, ºÎ»ê »çÇϱ¸ À帲µ¿, ºÎ»ê ¼ö¿µ±¸ ±¤¾È4µ¿, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ÀÎõ¹«¸­°üÀý¿°Ä¡·á ãÀ¸½Ã´Â ¿¬¼öµ¿, ³²±¸, Á¤¿Õµ¿, ºÀ´ãÀ¾, »óµ¿, ¿î¼­µ¿, ³²µ¿±¸, Áß±¸, ¼Û¿ùµ¿, ÀÎõ³íÇö, Áßµ¿, ¼®³²µ¿, µ¿±¸, ³²¾çÀ¾, µ¿Ãᵿ, ¼±Çе¿, ºñºÀ¸é, ¼þÀǵ¿, ¹è°ð½Åµµ½Ã, ½ÃÈï, °¡Áµ¿, °Ë¾Ï, ¼Ûµµ, ¼Û¸²µ¿, °£¼®µ¿, °è»êµ¿, ¼Ûµµ½Åµµ½Ã, ¹è°ð, ¿µÁ¾µµ, û¶ó, ¸¸¼öµ¿, ÀÛÀüµ¿, ÇÐÀ͵¿, ¿µÈïµµ, ±¸¿ùµ¿ µî ÀÎõ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿øÀÎõÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. Lee SS, Sohn YW, Yoo ES, Kim KH. Neurotoxicity and long lasting analgesia induced by capsaicinoids. J Toxicol Sci 1991; 16 Suppl 1:3. 2. Herr K, Coyne PJ, Key T, et al. Pain assessment in the nonverbal patient: position statement with clinical practice recommendations. Pain Manag Nurs 2006; 7:44. 3. Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 2005; 96:399. 4. Feldt KS, Ryden MB, Miles S. Treatment of pain in cognitively impaired compared with cognitively intact older patients with hip-fracture. J Am Geriatr Soc 1998; 46:1079. 5. http://www.fda.gov/drugs/drugsafety/informationbydrugclass/ucm239871.htm (Accessed on June 06, 2014). 6. Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst Rev 2009; :CD007115. 7. Smith HS. Potential analgesic mechanisms of acetaminophen. Pain Physician 2009; 12:269. 8. Watkins PB, Kaplowitz N, Slattery JT, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006; 296:87. 9. Kroenke K, Krebs EE, Wu J, et al. Telecare collaborative management of chronic pain in primary care: a randomized clinical trial. JAMA 2014; 312:240.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõ¹«¸­°üÀý¿° Ä¡·á ´Ù¾çÇÑ Ä¡·á¸¦""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎõ»ç¸¶±Í ÇÑÀÇ¿ø ´Ù¾çÇÑ Ä¡·á¸¦
´ÙÀ½±Û ÀÎõ´Ù³¶¼º³­¼ÒÁõÈıº ÇÑÀÇ¿ø Ãʱ⿡ °ü¸®ÇØ¿ä
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
692 ÇØÀ²ÇÑÀÇ¿ø, È«´ë¿©µå¸§º´¿ø 4¿ù À̺¥Æ® ½Ç½ÃÇØ¿ä 0 2,037 2020-04-10
691 ¿¹ÀÛÇÑÀÇ¿ø, ºÎ»ê °æ³² ´ÙÀ̾îÆ® ºÎ°æ¸¾ ÇÒÀÎ À̺¥Æ®!!! Ãâ»ê ÈÄ »ìÀÌ .. 0 1,124 2020-04-01
690 ÇÏ´ÃüÇÑÀÇ¿ø Á¦ÁÖÁ¡ µîµå¸§ ÄɾîÄ¡·á À̺¥Æ® 0 1,895 2020-04-01
689 ÇÏ´ÃüÇÑÀÇ¿ø ÀÏ»êÁ¡ 4¿ù À̺¥Æ®ÀÔ´Ï´Ù 0 2,231 2020-04-01
688 ¼öÇÑÀÇ¿ø, »ê»ïºñ¸¸¾àħÀ̺¥Æ® 0 2,299 2020-04-01
687 ¸é¿ª·Â ³ôÀ̱â, ÅÂÈï´ç ÇѾà ÇÒÀÎ ÇýÅà 0 1,269 2020-03-30
686 È®ÂðÀÚ¸¦ À§ÇÑ °¨ºñȯ À̺¥Æ®°¡ ½ÃÀ۵˴ϴÙ-¸¶»ê´ÙÀ̾îÆ® ÇÑÀÇ¿ø 0 2,043 2020-03-30
685 ½Å»çÀÓ´çÇÑÀÇ¿ø ´ÙÀ̾îÆ® À̺¥Æ® 3 2,987 2020-03-30
684 ÇØÀ²ÇÑÀÇ¿ø È«´ëÁ¡ 2020³â 3¿ù °¡°Ý À̺¥Æ® ¾È³» 0 7,659 2020-03-25
683 ¸é¿ª·Â¿¡ ÁÁÀº °æ¿Á°í(½ºÆ½Çü)-±â°üÁö °Ç°­¿¡ È¿°ú-¸¶»êº½º½ÇÑÀÇ¿ø 0 2,975 2020-03-02
682 3¿ù ÂüÇÑÀÇ¿ø °æ¿Á°í ÇÒÀÎÀ̺¥Æ® 0 997 2020-03-02
681 2¿ù ´ÙÀ̾îÆ® ÇÒÀÎ À̺¥Æ®! ³¡³ª±â Àü¿¡ ¼­µÎ¸£¼¼¿ä¢½ ½Å¸² ´ÙÀ̾îÆ® .. 0 2,813 2020-02-27
680 ¼­¿ï°æÈñÇÑÀÇ¿ø, STARTOVER µðÅ彺ÇÁ·Î±×·¥ À̺¥Æ® 0 1,177 2020-02-24
679 ûÁÖ ¸¶À½¿¡ ²É ÇÑÀÇ¿ø ¸é¿ªÁõ°­ À̺¥Æ® 2 1,132 2020-02-24
678 ¼ö¿ø´ãÀûÇÑÀÇ¿ø À̺¥Æ® ÁøÇàÇÕ´Ï´Ù 0 4,880 2020-02-11
677 2¿ù ÂüÇÑÀÇ¿ø ÇÒÀÎ ÇÁ·Î¸ð¼Ç 0 907 2020-02-07
676 ÀºÇ೪¹«ÇÑÀÇ¿ø 2¿ùÀ̺¥Æ® °Ü¿ï¹æÇÐÀ̺¥Æ® 0 1,166 2020-02-07
675 ¼öÇÑÀÇ¿ø 2¿ù À̺¥Æ® "»õ³»±â º¸¾à À̺¥Æ®" 0 906 2020-02-07
674 2¿ù À̺¥Æ® »ç»ïûÆóÀ½ -[¸¶»êº½º½ÇÑÀÇ¿ø] 0 2,168 2020-02-04
673 ÇØÀ²ÇÑÀÇ¿ø ÀÎõÁ¡ 2¿ù À̺¥Æ® °øÁö 0 1,298 2020-02-04
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷